- Home
- LFCR vs STHO Comparison
LFCR vs STHO Comparison
Compare LFCR & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- STHO
- Stock Information
- Founded
- LFCR 1986
- STHO N/A
- Country
- LFCR United States
- STHO United States
- Employees
- LFCR N/A
- STHO N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- STHO Real Estate
- Sector
- LFCR Health Care
- STHO Real Estate
- Exchange
- LFCR Nasdaq
- STHO Nasdaq
- Market Cap
- LFCR 164.3M
- STHO 153.3M
- IPO Year
- LFCR N/A
- STHO N/A
- Fundamental
- Price
- LFCR $7.17
- STHO $9.63
- Analyst Decision
- LFCR Buy
- STHO
- Analyst Count
- LFCR 2
- STHO 0
- Target Price
- LFCR $10.00
- STHO N/A
- AVG Volume (30 Days)
- LFCR 209.5K
- STHO 77.6K
- Earning Date
- LFCR 01-02-2025
- STHO 11-05-2024
- Dividend Yield
- LFCR N/A
- STHO N/A
- EPS Growth
- LFCR N/A
- STHO N/A
- EPS
- LFCR 0.17
- STHO 6.15
- Revenue
- LFCR $128,443,999.00
- STHO $117,752,000.00
- Revenue This Year
- LFCR $2.23
- STHO N/A
- Revenue Next Year
- LFCR $8.40
- STHO N/A
- P/E Ratio
- LFCR $50.46
- STHO $1.51
- Revenue Growth
- LFCR 23.42
- STHO 13.35
- 52 Week Low
- LFCR $3.68
- STHO $9.23
- 52 Week High
- LFCR $8.90
- STHO $15.31
- Technical
- Relative Strength Index (RSI)
- LFCR 48.90
- STHO 18.97
- Support Level
- LFCR $6.85
- STHO $10.06
- Resistance Level
- LFCR $7.88
- STHO $10.47
- Average True Range (ATR)
- LFCR 0.42
- STHO 0.32
- MACD
- LFCR -0.11
- STHO -0.08
- Stochastic Oscillator
- LFCR 18.93
- STHO 5.77
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. It focuses on realizing value for shareholders from the legacy portfolio by maximizing cash flows through active asset management and asset sales.